Papavasiliou A V, Isaac D L, Marimuthu R, Skyrme A, Armitage A
Orthopaedic Department, Eastbourne District General Hospital NHS Trust, Kings Drive, Eastbourne BN21 2UD, UK.
J Bone Joint Surg Br. 2006 Mar;88(3):321-3. doi: 10.1302/0301-620X.88B3.17136.
We reviewed 231 patients who had undergone total knee replacement with an AGC (Biomet) implant over a period of 2.5 years. After applying exclusion criteria and with some loss to follow-up, there were 144 patients available for study. These were divided into two groups; those who had received intra-articular steroid in the 11 months before surgery and those who had not. There were three deep infections, all of which occurred in patients who had received a steroid injection. The incidence of superficial infection was not significantly different in the two groups. Five patients had undergone investigation for suspected deep infection because of persistent swelling or pain and all of these had received an intra-articular injection pre-operatively. We conclude that the decision to administer intra-articular steroids to a patient who may be a candidate for total knee replacement should not be taken lightly because of a risk of post-operative deep infection.
我们回顾了231例在2.5年期间接受AGC(Biomet)植入物全膝关节置换术的患者。应用排除标准并排除部分失访病例后,有144例患者可供研究。这些患者被分为两组,一组是在手术前11个月内接受过关节内注射类固醇的患者,另一组是未接受过的患者。发生了3例深部感染,均发生在接受过类固醇注射的患者中。两组浅表感染的发生率无显著差异。5例患者因持续肿胀或疼痛接受了疑似深部感染的检查,所有这些患者术前均接受过关节内注射。我们得出结论,对于可能接受全膝关节置换术的患者,不应轻易决定给予关节内类固醇,因为存在术后深部感染的风险。